Related Experiment Video
Updated: Aug 7, 2026

Enrichment of Bruch's Membrane from Human Donor Eyes
Published on: November 15, 2015
Complement factor H increases risk for atrophic age-related macular degeneration
Eric A Postel1, Anita Agarwal, Jennifer Caldwell
1Duke University Eye Center, Durham, North Carolina, USA. poste002@mc.duke.edu
Insights
The complement factor H gene (CFH) is linked to an increased risk of developing geographic atrophy (GA), a significant cause of vision loss in age-related macular degeneration (AMD). This finding highlights the importance of understanding CFH
Area of Science:
- Ophthalmology and Genetics
- Molecular Biology and Disease Pathogenesis
Background:
- Geographic atrophy (GA) and neovascular age-related macular degeneration (AMD) are leading causes of irreversible vision loss.
- The complement factor H gene (CFH) has been implicated in AMD pathogenesis, but its specific role in GA development requires further clarification.
Purpose of the Study:
- To investigate the association between the complement factor H gene (CFH) and the risk of developing geographic atrophy (GA).
- To determine if specific single-nucleotide polymorphisms (SNPs) in the CFH gene are predictive of GA development in patients with AMD.
Main Methods:
- A retrospective case-control study was conducted using a dataset of 647 AMD cases (grades 3-5) and 163 controls (grades 1-2).
- The rs1061170 SNP within the CFH gene was analyzed for association with AMD affection status.
- Logistic regression models were employed to calculate odds ratios, with genotypes coded using a log-additive model.
Main Results:
- A significant association was found between CFH gene variants and AMD, particularly when comparing advanced stages (grades 3-5) to controls.
- The highest odds ratio (OR = 3.217, P<0.0001) was observed in grade-4 GA cases compared to grade-1 controls.
- The study identified a strong correlation between CFH and the risk of developing GA and other forms of AMD.
Conclusions:
- The complement factor H gene (CFH) significantly increases the risk of developing geographic atrophy (GA) and other forms of age-related macular degeneration (AMD).
- Given that GA is a major cause of vision loss, understanding its pathogenesis, potentially involving CFH, is crucial for developing effective treatments.
- Further research into the role of CFH in GA pathogenesis is warranted due to its significant impact on vision.
Objective:
To determine if the complement factor H gene (CFH) determines risk for development of geographic atrophy (GA).
Design:
Retrospective case-control study.
Participants And Controls:
The independent case-control data set contained 647 age-related macular degeneration (AMD) cases (grades 3, 4, or 5) and 163 controls (grades 1 or 2).
Methods:
To determine if CFH had any effect on determining risk for development of GA in an independent case-control data set of 647 AMD cases and 163 controls, the rs1061170 single-nucleotide polymorphism was tested for association, separating grades and analyzing them independently against the controls. Odds ratios were calculated using standard logistic regression models.
Main Outcome Measures:
The outcome variable was AMD affection status, and genotypes were coded according to a log-additive model.
Results:
There were 407 grade 5, 107 grade 4, 133 grade 3, 35 grade 2, and 128 grade 1 individuals. There was significant association with AMD when comparing grades 3, 4, and 5 versus the controls. The highest odds ratio was obtained when analyzing the grade-4 cases versus the grade-1 controls (OR = 3.217, P<0.0001).
Conclusions:
Our results indicate that CFH increases the risk of developing GA (grade 4) as well as neovascular (grade 5) and milder (grade 3) disease. Although neovascular disease is responsible for the majority of severe vision loss with AMD, GA is also a significant cause of vision loss, and without effective treatment. Therefore, an attempt to clarify its pathogenesis is of the utmost importance.
Related Concept Videos
Diabetic Retinopathy
Rheumatic Heart Disease I: Introduction

